Our Pricing

Wegovy 1mg Side Effects: Complete Starter Guide

Understanding wegovy 1mg side effects uk is essential for patients starting their weight loss journey with semaglutide. At Cured Pharmacy, our UK-registered clinical team has supported thousands of patients through their Wegovy treatment, and this guide draws on that experience to help you navigate the starter phase with confidence. Most side effects are mild, temporary, and manageable with the right strategies.

Common Wegovy 1mg Side Effects in the First Month

The 1mg dose represents the third step in the Wegovy titration schedule, typically reached after 8 weeks of treatment [1]. At this stage, your body has already adapted to lower doses (0.25mg and 0.5mg), which significantly reduces the severity of gastrointestinal side effects compared to starting at higher doses.

In the STEP 1 clinical trial involving 1,961 participants, the most frequently reported side effects at the 1mg dose were nausea (affecting approximately 44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. However, these figures represent the peak incidence across all doses, with the 1mg level typically producing milder symptoms than higher maintenance doses.

Most gastrointestinal symptoms emerge within 24-72 hours of your injection and diminish over the following 3-5 days as semaglutide levels stabilise [2]. The gradual dose escalation protocol exists specifically to minimise these effects whilst allowing your body to adapt to the medication's appetite-suppressing mechanisms.

Injection Site Reactions at 1mg

Local injection site reactions occur in approximately 8-12% of patients at the 1mg dose [1]. These typically present as mild redness, itching, or small raised bumps at the injection site that resolve within 2-4 days. Rotating your injection sites between the abdomen, thigh, and upper arm each week significantly reduces the risk of persistent reactions. If you notice hardening, significant swelling, or warmth spreading beyond the immediate injection area, contact your prescriber as these may indicate a more serious reaction requiring assessment.

Managing Wegovy Nausea: Evidence-Based Strategies

Nausea represents the most common side effect reported during Wegovy treatment, but it's also the most manageable with targeted strategies [2]. The mechanism behind semaglutide-induced nausea involves delayed gastric emptying and direct effects on nausea centres in the brain — understanding this helps explain why certain management approaches work better than others.

Eat smaller, more frequent meals rather than three large ones. Semaglutide slows stomach emptying, so large meals can trigger prolonged fullness and nausea. Aim for 5-6 small portions throughout the day, focusing on bland, low-fat foods during the first 72 hours post-injection when nausea peaks. Avoid lying down immediately after eating, as this exacerbates delayed gastric emptying.

Stay well-hydrated with small, frequent sips rather than large volumes at once. Ginger tea, peppermint tea, and cold water are often better tolerated than warm beverages. If nausea prevents adequate fluid intake for more than 24 hours, contact your prescriber as dehydration can worsen symptoms and may require temporary dose adjustment.

Time your injection strategically. Many patients find injecting in the evening before bed allows them to sleep through the initial nausea peak. Others prefer morning injections with a light breakfast. Experiment during your lower doses to identify your optimal timing before reaching 1mg.

Serious Side Effects: When to Seek Urgent Medical Attention

Whilst most Wegovy side effects are mild and self-limiting, certain symptoms require immediate medical assessment. Pancreatitis, though rare (occurring in approximately 0.2% of patients in clinical trials), represents the most serious potential complication [1]. Symptoms include severe, persistent abdominal pain radiating to your back, often accompanied by nausea and vomiting that doesn't improve with usual management strategies.

Gallbladder problems occurred in 1.6% of Wegovy patients versus 0.7% of placebo patients in STEP trials [1]. Seek urgent medical attention if you experience sudden, severe pain in the upper right abdomen, yellowing of skin or eyes, fever with abdominal pain, or clay-coloured stools. These may indicate gallstones or cholecystitis requiring immediate intervention.

Allergic reactions to semaglutide are uncommon but require emergency care. Stop using Wegovy and call 999 if you develop swelling of your face, lips, tongue, or throat, difficulty breathing or swallowing, severe rash or itching, or feeling faint or dizzy. These symptoms may indicate anaphylaxis, a medical emergency.

Changes in vision, persistent severe headaches, or symptoms of hypoglycaemia (shakiness, confusion, rapid heartbeat, sweating) — particularly if you're taking other diabetes medications — warrant same-day contact with your prescriber. Whilst Wegovy alone rarely causes low blood sugar, the combination with other medications can increase this risk [2].

Thyroid Monitoring Requirements

Semaglutide carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [1]. You should not use Wegovy if you or any family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Report any neck lump, persistent hoarseness, difficulty swallowing, or shortness of breath to your prescriber immediately, as these may indicate thyroid abnormalities requiring investigation.

Wegovy Side Effects First Week vs Ongoing Treatment

The side effect profile changes significantly as you progress through Wegovy's dose escalation schedule. During your first week at 1mg, you may notice an increase in gastrointestinal symptoms compared to the 0.5mg dose, but this typically represents a temporary adjustment period rather than a sustained worsening [2].

Clinical trial data shows that nausea severity peaks during weeks 2-4 of treatment (when patients are on the lowest doses) and gradually improves despite dose increases, suggesting physiological adaptation occurs over time [1]. By week 12-16, most patients report substantially reduced nausea even at the 2.4mg maintenance dose compared to their experience at lower doses.

Approximately 68% of patients who experience nausea at the 1mg dose report improvement or resolution by their third injection at this level [2]. The key is distinguishing between expected adjustment symptoms and persistent, severe reactions that may warrant dose modification. If you're still experiencing moderate-to-severe nausea affecting daily activities after three consecutive weeks at 1mg, contact your prescriber to discuss whether staying at this dose longer before escalating would be appropriate.

Fatigue and headaches, reported by 11% and 14% of patients respectively, often follow a different pattern, sometimes emerging later in treatment [1]. These typically respond well to ensuring adequate hydration, maintaining consistent meal timing despite reduced appetite, and avoiding rapid dietary changes that can affect energy levels.

Dietary Modifications to Minimise Wegovy Side Effects

Strategic dietary choices can significantly reduce the severity and duration of Wegovy side effects, particularly during the 1mg dose phase. The medication's mechanism of slowing gastric emptying means that food composition and timing directly impact your symptom experience [2].

Prioritise protein and avoid high-fat meals during the first 72 hours post-injection. Fatty foods delay gastric emptying even further, compounding semaglutide's effects and prolonging fullness and nausea. Lean proteins like chicken, white fish, eggs, and low-fat Greek yoghurt are typically well-tolerated and help maintain satiety without triggering symptoms.

Avoid carbonated beverages, alcohol, and spicy foods during your peak symptom window. Carbonation increases gastric distension when emptying is already delayed, whilst alcohol can exacerbate nausea and dehydration. Spicy foods may trigger acid reflux, which affects approximately 9% of Wegovy patients [1].

Consider keeping a food and symptom diary during your first month at 1mg. This helps identify your personal trigger foods and optimal eating patterns. Many patients find that what they could tolerate at 0.5mg becomes problematic at 1mg, requiring temporary dietary adjustments until adaptation occurs.

Fibre intake requires careful balancing. Whilst adequate fibre helps prevent constipation (a common side effect), excessive fibre combined with delayed gastric emptying can worsen bloating and discomfort. Aim for moderate, consistent fibre intake from easily digestible sources like oats, cooked vegetables, and berries rather than sudden increases in raw vegetables or bran.

Hydration Strategies for Wegovy Patients

Maintaining adequate hydration becomes more challenging on Wegovy due to reduced thirst signals and nausea affecting fluid intake. Aim for at least 2 litres daily, consumed in small amounts throughout the day rather than large volumes at once. Cold water, herbal teas, and diluted electrolyte drinks are often better tolerated than room-temperature water or sugary beverages. If you're experiencing vomiting or diarrhoea, increase fluid intake and consider oral rehydration solutions to replace lost electrolytes.

Starting Wegovy 1mg at Cured Pharmacy: What to Expect

At Cured Pharmacy, we provide Wegovy from £79.00 with transparent upfront pricing and comprehensive clinical support throughout your treatment journey. Our UK-registered prescribers assess your suitability through a free online consultation taking under 3 minutes, ensuring Wegovy is appropriate for your individual circumstances before prescribing.

Your treatment begins with the 0.25mg starter dose, progressing through 0.5mg before reaching 1mg at week 9 of treatment, subject to your prescriber's assessment and your tolerance of previous doses [1]. This gradual escalation protocol is designed specifically to minimise side effects whilst optimising weight loss outcomes. Superintendent pharmacist Tarun Kumar (GPhC 2233073) and our clinical team are available to support you with side effect management strategies throughout your treatment.

We dispense only genuine UK-licensed Wegovy pens with full patient information leaflets and injection guidance. All medications are shipped in 100% discreet packaging with next-day delivery options available. As a GPhC-registered pharmacy (9012511), we adhere to strict regulatory standards ensuring you receive the same quality care as you would from any UK high-street pharmacy.

If you experience concerning side effects at the 1mg dose, our clinical team can arrange prescriber review to discuss dose modification, extended time at your current dose, or alternative weight loss treatments. Treatment adjustments are common and do not represent treatment failure — individualising your dose schedule often improves both tolerability and long-term adherence.

Ongoing Clinical Monitoring

Regular monitoring ensures safe, effective treatment. Your prescriber will review your progress, side effects, and weight loss response at scheduled intervals, typically every 12 weeks during the dose escalation phase. Blood pressure monitoring and assessment for gallbladder symptoms form part of routine follow-up. If you have pre-existing diabetes, more frequent monitoring of blood glucose levels may be recommended, particularly during dose increases. Contact our team on (+44) 116 4646009 if you have questions between scheduled reviews.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial). New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://www.gov.uk/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and requires online clinical assessment before it can be dispensed by Cured Pharmacy.